QQ客服 官方微博 反馈留言

	Real-world data on EGFR/ALK gene status and first-line targeted therapy rate in newly diagnosed advanced non-small cell lung cancer patients in Northern China: A prospective observational study
	Liang Hongge; Song Xia; Zhang Yuhui; Zhang Shucai; Li Fang; Fang Jian; Li Junling; Liang Li; Nie Ligong; Ma Kewei
	2019
卷号	10期号:7页码:1521-1532
关键词	ALK rearrangement EGFR mutation evaluation status non-small cell lung cancer
ISSN号	1759-7714
DOI	10.1111/1759-7714.13090
URL标识	查看原文
收录类别	PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6340804
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Liang Hongge,Song Xia,Zhang Yuhui,et al. Real-world data on EGFR/ALK gene status and first-line targeted therapy rate in newly diagnosed advanced non-small cell lung cancer patients in Northern China: A prospective observational study[J],2019,10(7):1521-1532.
APA	Liang Hongge.,Song Xia.,Zhang Yuhui.,Zhang Shucai.,Li Fang.,...&Wang Mengzhao.(2019).Real-world data on EGFR/ALK gene status and first-line targeted therapy rate in newly diagnosed advanced non-small cell lung cancer patients in Northern China: A prospective observational study.,10(7),1521-1532.
MLA	Liang Hongge,et al."Real-world data on EGFR/ALK gene status and first-line targeted therapy rate in newly diagnosed advanced non-small cell lung cancer patients in Northern China: A prospective observational study".10.7(2019):1521-1532.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。